Policy | July 03, 2022
Time to move from ‘Volume’ to ‘Value’ leadership to capture global market, says Mandaviya
Govt committed to supporting pharma companies with industry-friendly policies
Govt committed to supporting pharma companies with industry-friendly policies
This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
This recommendation is based on new data from two randomized controlled trials involving 3078 patients
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
Subscribe To Our Newsletter & Stay Updated
